GlaxoSmithKline's net profit under IFRS for 9 months of 2020 was £5.549 billion, up 47.9% from £3.751 billion the previous year. Revenue increased by 2% to £25.36 billion from £24.855 billion a year earlier.
GlaxoSmithKline's net profit under IFRS for 9 months of 2020 was £5.549 billion, up 47.9% from £3.751 billion the previous year. Revenue increased by 2% to £25.36 billion from £24.855 billion a year earlier. 
gsk.com
English (US) 